NCT00902772View on ClinicalTrials.gov

Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant Users

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2009

Study Completion Date

September 30, 2009

Conditions
Recreational CNS Depressant Use
Interventions
DRUG

Lorazepam

mg, oral dose

DRUG

AZD7325

mg, oral dose

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Toronto

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY